Galectin-3 is a known marker of cardiac fibrosis; higher levels of this protein have been previously shown to be associated with an increased risk of heart failure and all-cause mortality in community populations, as well as with risk of morbidity and mortality amongst patients with heart failure. Here, LGALS3 is linked to heart failure.